As we highlighted the role of each homologous recombination factors (RAD21, RAD50 or BARD1) to patients’ survival and cancer aggressiveness in bladder cancer, other groups studied these factors in different cancer types22,24,28,43,65,66. This evidence concerns the gene RAD50 and cancer.